95 related articles for article (PubMed ID: 3087532)
21. Immunise Australia program: measles control campaign.
Commun Dis Intell; 1998 Aug; 22(8):156. PubMed ID: 9735549
[No Abstract] [Full Text] [Related]
22. Measles vaccination.
Norrby EC
Bull Pan Am Health Organ; 1976; 10(3):196-7. PubMed ID: 1000095
[TBL] [Abstract][Full Text] [Related]
23. CLINICAL AND SEROLOGICAL OBSERVATIONS ON THE CHILDREN GIVEN ATTENUATED MEASLES VACCINE.
ARAI M; NAKAMURA M; AKAMATSU T; KIMURA M; KITAYAMA T; KOIDE G
Acta Paediatr Jpn; 1963 Dec; 14():9-16. PubMed ID: 14200614
[No Abstract] [Full Text] [Related]
24. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
[TBL] [Abstract][Full Text] [Related]
25. Measles and measles vaccine in Japan.
Isomura S
Nagoya J Med Sci; 1993 Mar; 55(1-4):23-32. PubMed ID: 8247103
[TBL] [Abstract][Full Text] [Related]
26. [Measles vaccination with split vaccines and living vaccines (author's transl)].
Stehr K; Enders-Ruckle G; Spiess H
MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710
[TBL] [Abstract][Full Text] [Related]
27. The status of measles after five years of mass vaccination in the USSR.
Burgasov PN; Andzaparidze OG; Popov VF
Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
[TBL] [Abstract][Full Text] [Related]
28. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles.
Polack FP; Lee SH; Permar S; Manyara E; Nousari HG; Jeng Y; Mustafa F; Valsamakis A; Adams RJ; Robinson HL; Griffin DE
Nat Med; 2000 Jul; 6(7):776-81. PubMed ID: 10888926
[TBL] [Abstract][Full Text] [Related]
29. Measles immunization: ignorance or apathy?
Honig FM
Aust J Adv Nurs; 1986; 3(2):4-12. PubMed ID: 3636152
[No Abstract] [Full Text] [Related]
30. [Vaccinations and serotherapy. Current problems].
Letonturier P
Minerva Med; 1973 Jun; 64(41):2135-46. PubMed ID: 4719824
[No Abstract] [Full Text] [Related]
31. Experimental studies on the prevention and treatment of chickenpox and herpes zoster with measles vaccine.
Li WH; Ming ZL; Chen Q; Li Y
Chin Med J (Engl); 1989 May; 102(5):395-9. PubMed ID: 2509165
[TBL] [Abstract][Full Text] [Related]
32. [Epidemiologic and clinical results of measles immunization in the district Karl-Marx-city].
Hajduk F; Hempel HC
Dtsch Gesundheitsw; 1968 Dec; 23(52):2483-9. PubMed ID: 5715950
[No Abstract] [Full Text] [Related]
33. [Mass vaccination against measles in Chile with Enders attenuated virus vaccine].
Ristori C; Boccardo H; Borgoño JM; Miranda M
Bol Oficina Sanit Panam; 1966 May; 60(5):396-400. PubMed ID: 4222614
[No Abstract] [Full Text] [Related]
34. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines.
Sabin AB; Flores Arechiga A; Fernández de Castro J; Sever JL; Madden DL; Shekarchi I; Albrecht P
JAMA; 1983 May; 249(19):2651-62. PubMed ID: 6341638
[TBL] [Abstract][Full Text] [Related]
35. Mass measles control in West and Central Africa.
Foster SO; Pifer JM
Afr J Med Sci; 1971 Apr; 2(2):151-8. PubMed ID: 5111614
[TBL] [Abstract][Full Text] [Related]
36. Clinical, antigenic and prophylactic effects of an inactivated measles virus vaccine.
Kapikian AZ; Bell JA; James RG; Holbrook Z
Am J Epidemiol; 1966 Jul; 84(1):138-49. PubMed ID: 5944729
[No Abstract] [Full Text] [Related]
37. Field effectiveness of live attenuated measles-containing vaccines: a review of published literature.
Uzicanin A; Zimmerman L
J Infect Dis; 2011 Jul; 204 Suppl 1():S133-48. PubMed ID: 21666154
[TBL] [Abstract][Full Text] [Related]
38. Reduced secretory antibody response to live attenuated measles and poliovirus vaccines in malnourished children.
Chandra RK
Br Med J; 1975 Jun; 2(5971):583-5. PubMed ID: 1131622
[TBL] [Abstract][Full Text] [Related]
39. Measles and mumps immunization: benefit versus risk factors.
Krugman S
Dev Biol Stand; 1979; 43():253-7. PubMed ID: 520672
[TBL] [Abstract][Full Text] [Related]
40. INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
KIMURA M; ISHIGURO Y
Jpn J Med Sci Biol; 1965 Feb; 18():65-71. PubMed ID: 14300296
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
